Biblio

Author Title Type [ Year(Desc)]
Filters: Author is Young, Neal S  [Clear All Filters]
2016
Dumitriu B, Ito S, Feng X, Stephens N, Yunce M, Kajigaya S, Melenhorst JJ, Rios O, Scheinberg P, Chinian F, et al. Alemtuzumab in T-cell large granular lymphocytic leukaemia: interim results from a single-arm, open-label, phase 2 study. Lancet Haematol. 2016;3(1):e22-e29.
Zhao X, Tian X, Kajigaya S, Cantilena CR, Strickland S, Savani BN, Mohan S, Feng X, Keyvanfar K, Dunavin N, et al. Epigenetic landscape of the TERT promoter: a potential biomarker for high risk AML/MDS. Br J Haematol. 2016.
Baljevic M, Dumitriu B, Lee J-W, Paietta EM, Wiernik PH, Racevskis J, Chen C, Stein EM, Gallagher RE, Rowe JM, et al. Telomere Length Recovery: A Strong Predictor of Overall Survival in Acute Promyelocytic Leukemia. Acta Haematol. 2016;136(4):210-218.
2020
Zaimoku Y, Patel BA, Kajigaya S, Feng X, Alemu L, Raffo DQuinones, Groarke EM, Young NS. Deficit of circulating CD19 CD24 CD38 regulatory B cells in severe aplastic anaemia. Br J Haematol. 2020.
Fan X, Desmond R, Winkler T, Young DJ, Dumitriu B, Townsley DM, Gutierrez-Rodrigues F, Lotter J, Valdez J, Sellers SE, et al. Eltrombopag for patients with moderate aplastic anemia or uni-lineage cytopenias. Blood Adv. 2020;4(8):1700-1710.
Beck DB, Ferrada MA, Sikora KA, Ombrello AK, Collins JC, Pei W, Balanda N, Ross DL, Cardona DOspina, Wu Z, et al. Somatic Mutations in and Severe Adult-Onset Autoinflammatory Disease. N Engl J Med. 2020.
2021
Batey K, Kim J, Brinster L, Gonzalez-Matias G, Wu Z, Solorzano S, Chen J, Feng X, Young NS. Residual effects of busulfan and irradiation on murine hematopoietic stem and progenitor cells. Exp Hematol. 2021.
2022
Young DJ, Fan X, Groarke EM, Patel B, Desmond R, Winkler T, Larochelle A, Calvo KR, Young NS, Dunbar CE. Long-term eltrombopag for bone marrow failure depletes iron. Am J Hematol. 2022.